EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›MTVA

MTVA

MetaVia Inc.

Next earnings Aug 5, 2026 · consensus $-0.84 EPS

Last earnings -0.8% on 2026-05-14

Sell
$1.43
▼ -6.54%
$1.43▼ -80.60%
over 1Y
L $0.97EODHDH $16.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-6.5%
1W-8.9%
1M-57.2%
3M+17.2%
YTD-85.0%
1Y-80.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C
Valuation
Fair value
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy

Mixed signals in the latest filings.

Return on equity -243.3% · latest

MetaVia Inc. shows limited reported revenue, and -243.3% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income-$15.3M-$19.6M-$15.9M-$28.8M-$13.7M
Net income-$15.3M-$14.0M-$12.5M-$27.6M-$13.0M
Diluted EPS-$19.81-$43.42-$2.46-$39.13-$7.35
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value-$3.00M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-178.2%
FCF yield-215.7%

Quality & risk

ROIC (est.)-203.1%
Free cash flow-$15.7M
Total debt—
Net cash$10.3M
Piotroski F-Score2/6

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-41.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-06-08
  2. 8-K Reg FD disclosure2026-06-08
  3. 8-K Reg FD disclosure2026-05-27
  4. 8-K Reg FD disclosure2026-05-18
  5. 8-K Earnings results2026-05-14
  6. 10-Q Quarterly report2026-05-14
  7. 8-K Reg FD disclosure2026-05-11
  8. DEF 14A Proxy statement2026-04-27
  9. 10-K Annual report2026-03-26

Recent filings

all on EDGAR ↗
4Period ending 2026-06-082026-06-08open ↗4Period ending 2026-06-082026-06-08open ↗4Period ending 2026-06-082026-06-08open ↗4Period ending 2026-06-082026-06-08open ↗4Period ending 2026-06-082026-06-08open ↗4Period ending 2026-06-082026-06-08open ↗S-8Filing2026-06-08open ↗8-KPeriod ending 2026-06-082026-06-08open ↗8-KPeriod ending 2026-06-082026-06-08open ↗8-KPeriod ending 2026-05-272026-05-27open ↗8-KPeriod ending 2026-05-182026-05-18open ↗SCHEDULE 13GFiling2026-05-15open ↗

Quality score

C
ValueGrowthProfitHealthMom.
Value—
GrowthA+
ProfitabilityF
Financial healthC+
Momentum—
  • ✗Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
—
Net margin
—
ROE
-243.3%
P/E
—

SEC fundamentals · FY 2025

■ revenue · ■ net income, by fiscal year

Net income-$13.0M+53.0%
Operating income-$13.7M+52.4%
Diluted EPS-$7.35+81.2%
Cash & equivalents$10.3M-35.8%
Total assets$11.1M-31.6%
Total liabilities$5.79M-30.5%
Stockholders' equity$5.33M-32.8%
L/E: 1.09x

Frequently asked

Is MetaVia Inc. (MTVA) a buy?
MTVA currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is MetaVia Inc.'s quality score?
MTVA scores 57.30769230769231/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001638287, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 1:10:24 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-08
Tursi James Patrick
Director
Award17.2K
2026-06-08
STRICKLAND D GORDON
Director
Award17.2K
2026-06-08
Salsbury Michael
Director
Award17.2K
2026-06-08
GROVES JASON L
Director
Award17.2K
2026-06-08
KOVEN ANDREW I
Director
Award17.2K
2026-06-08
Glickman Mark A
Director
Award17.2K
2026-01-23
Woodworth Marshall H
Chief Financial Officer
Award28.0K
2026-01-23
Kim Hyung Heon
CEO & President
Award32.0K

Earnings history

beat/miss · move
2026-05-14Miss -4.2% est▼ -0.83%8-K ↗
2026-03-26Beat +66.9% est▲ +1.54%8-K ↗
2026-01-05Beat +66.9% est▼ -8.68%8-K ↗
2025-11-06Beat +38.2% est▼ -15.00%8-K ↗
2025-08-07Beat +17.8% est▲ +2.91%8-K ↗
2025-05-14—▲ +2.62%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand ViewingBullish
globenewswire.com· 2026-06-26
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live streamBullish
finance.yahoo.com· 2026-06-09
Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On WatchBullish
nasdaq.com· 2026-05-26
MTVA Gains Weight, CODX Takes A Shot At Ebola, EDSA To Reveal New Data, BDTX On WatchBullish
nasdaq.com· 2026-05-20
Sector Update: Healthcare Stocks Gain Late Afternoon
finance.yahoo.com· 2026-05-19
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
finance.yahoo.com· 2026-05-19

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score57 vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity-243.3% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 5d
Neutral
-0.03
vs typical · 6 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.